DAFNA Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-100,000	Closed	-$1.76M	–	81
2021 Q2	$1.76M	Buy	+100,000	New	+$1.76M	0.37%	53